Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Examines in Physical Medicine & Rehabilitation

Atypical Antipsychotic as Add-on Therapy in Obsessive Compulsive Disorder

  • Open or CloseShoja Shafti S*

    Department of Psychiatry, Iran

    *Corresponding author: Shoja Shafti S, University of Social Welfare and Rehabilitation sciences (USWR), Razi Psychiatric Hospital, Tehran, Iran Submission:

Submission: May 07, 2018;Published: February 05, 2019

DOI: 10.31031/EPMR.2019.02.000534

ISSN: 2637-7934
Volume2 Issue2

Abstract

In an 8-week, open-label study, 54% (n=6) of treatment-resistant obsessive-compulsive patients (n=11) responded to adding olanzapine to current antidepressant treatment, with a mean reduction of 24.56% in YBOCS, as the primary outcome measure.

Keywords: Obsessive-compulsive disorder; Serotonin reuptake inhibitors; Olanzapine; Treatment resistant

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com